Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Business Times.
Press releases published on May 6, 2025
Renown Capital Partners formally launches with $250M in anchor capital, leads Series C raise for Utilidata
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Renown Capital Partners, (“Renown”) - an investment firm focused on growth-stage technology companies helping to secure an efficient, affordable, and reliable energy system - has formally launched. Renown is a …
Unveiling the Future of Trailer & Container Security: The Tive Security Seal
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Tive, the global leader in supply chain and logistics visibility technology, today announced that the company has partnered with TydenBrooks, the global leader in security seals and solutions, to deliver the Tive …
NAR Report Reveals Home Staging Boosts Sale Prices and Reduces Time on Market
GlobeNewswire
·
May 6, 2025
WASHINGTON, May 06, 2025 (GLOBE NEWSWIRE) -- Key Highlights Twenty-nine percent of real estate agents reported that staging their sellers’ homes received a 1% to 10% increase in the dollar value offered. When homes were staged, 30% of home sellers’ real …
Gordian Awarded Sourcewell National Cooperative Contract for Facility Assessments and Planning Services
GlobeNewswire
·
May 6, 2025
Greenville, SC, May 06, 2025 (GLOBE NEWSWIRE) -- Gordian, provider of data-driven solutions for all phases of the building lifecycle, announced today its award of a new Sourcewell contract, expanding Gordian’s offering to Sourcewell members to provide more …
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
GlobeNewswire
·
May 6, 2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases
GlobeNewswire
·
May 6, 2025
Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing Phase 1a/b study of PALI-2108 and has …
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
GlobeNewswire
·
May 6, 2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development …
Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference
GlobeNewswire
·
May 6, 2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today …
Great Lakes Reports First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
First quarter net income of $33.4 million First quarter Adjusted EBITDA of $60.1 million Dredging backlog of $1 billion at March 31, 2025 HOUSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Great Lakes Dredge …
Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 6, 2025
NXP900 clinical data presentation from the Phase 1a dose escalation study at the 2025 American Association for Cancer Research (AACR) conference demonstrated robust pharmacodynamic response and acceptable safety at clinically relevant doses; preclinical …
Uniti Group Inc. Reports First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
Updates 2025 Outlook Net Income of $12.2 Million for the First Quarter Net Income of $0.05 Per Diluted Common Share for the First Quarter AFFO of $0.35 Per Diluted Common Share for the First Quarter LITTLE ROCK, Ark., May 06, 2025 (GLOBE NEWSWIRE) -- Uniti …
AMRT Satellite Technology Uncovers Significant Mineral Assets at Historic Oregon Mine
EIN Presswire
·
May 6, 2025
Abandoned Mine Expected to Roar Back to Life with Massive Results thanks to AMRT Satellite Scan Technology MESA, AZ, UNITED STATES, May 6, 2025 /EINPresswire.com/ -- CC Explorations, a leading satellite-based mineral exploration company, today announced …
Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David …
Avalyn Announces Multiple Presentations on AP01 and AP02 for Pulmonary Fibrosis at the American Thoracic Society 2025 International Conference
GlobeNewswire
·
May 6, 2025
Topline Results from the AP02 (Inhaled Nintedanib) Phase 1 Clinical Trials Among the Company’s Five Poster Presentations 4.5 Year Long-Term Safety and Efficacy Data Supporting AP01 (Inhaled Pirfenidone) from the ATLAS Open-Label Extension Trial to be …
L.B. Foster Announces 2025 First Quarter Results; Maintaining 2025 Full Year Financial Guidance Driven by Strong Order Book Development
GlobeNewswire
·
May 6, 2025
Sales and profitability down from last year's exceptionally-strong first quarter due to lower demand in Rail Distribution; Infrastructure sales were up 5.0% year over year driven by Precast Concrete growth. Strong order rates across the portfolio increased …
Corbus Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
May 6, 2025
Dose optimization and RP2D determination on schedule for completion in Q4 2025 for the Nectin-4 ADC CRB-701 in HNSCC, cervical and mUC tumors SAD/MAD study on schedule for completion in Q3 2025 for the anti-obesity CB1 inverse agonist CRB-913 Dose …
Park Place Technologies Expands Multi-Cloud Services with Acquisition of UK-Based CSI
GlobeNewswire
·
May 6, 2025
CLEVELAND, OH, May 06, 2025 (GLOBE NEWSWIRE) -- Park Place Technologies, the leading global data center and networking optimization firm, has acquired CSI Ltd., a UK-headquartered IT Managed Services Provider (MSP) specializing in hybrid multi-cloud …
Quoin Pharmaceuticals to Announce First Quarter 2025 Financial Results on Tuesday, May 13, 2025
GlobeNewswire
·
May 6, 2025
ASHBURN, Va., May 06, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its …
Cogent Biosciences Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Three Registration-Directed Top-line Data Readouts Remain on Track in 2025: SUMMIT in NonAdvanced SM expected in July, APEX in Advanced SM expected in second half of the-year and PEAK in GIST expected by end of year Ended 1Q 2025 with $245.7 million in …
IPG Photonics Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
Growth from Strategic Initiatives Drove Revenue Above the Midpoint of Guidance Book-to-Bill was Above One and Highest in Over Two Years MARLBOROUGH, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- IPG Photonics Corporation (NASDAQ: IPGP) today reported financial …